benzoylarginine ethyl ester has been researched along with Disease Exacerbation in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fleckenstein, B; Halvorsen, EH; Kvien, TK; Molberg, O; Pollmann, S; Sollid, LM; Stensland, M | 1 |
Bhatia, M; Catchings, KL; Glascock, MC; Jones, NG; Kearney, PL; Thompson, PR; Yamada, M; Yuan, L | 1 |
2 other study(ies) available for benzoylarginine ethyl ester and Disease Exacerbation
Article | Year |
---|---|
Anti-PAD4 autoantibodies in rheumatoid arthritis: levels in serum over time and impact on PAD4 activity as measured with a small synthetic substrate.
Topics: Arginine; Arthritis, Rheumatoid; Autoantibodies; Biomarkers; Case-Control Studies; Catalysis; Disease Progression; Humans; Hydrolases; Immunoassay; Immunoglobulin G; Kinetics; Norway; Protein-Arginine Deiminase Type 4; Protein-Arginine Deiminases; Severity of Illness Index; Substrate Specificity | 2012 |
Kinetic characterization of protein arginine deiminase 4: a transcriptional corepressor implicated in the onset and progression of rheumatoid arthritis.
Topics: Amino Acid Sequence; Ammonia; Arginine; Arthritis, Rheumatoid; Calcium; Catalysis; Disease Progression; Histones; Humans; Hydrogen-Ion Concentration; Hydrolases; Hydrolysis; Kinetics; Methylation; Molecular Sequence Data; Peptides; Protein-Arginine Deiminase Type 4; Protein-Arginine Deiminases; Recombinant Proteins; Repressor Proteins; Substrate Specificity | 2005 |